Public Cord Blood Bank HLA Matching Service

Most allogeneic cord blood transplants use cord blood obtained from public banks. Public cord blood banks maintain cell resources with a diverse range of HLA types, giving patients who did not privately store cord blood—or whose stored cord blood is not suitable for use—an opportunity to find a suitable source for transplantation.

Privately stored cord blood typically consists of a single unit, which may not contain a sufficient number of cells for an adult patient. If the cord blood is intended for use by a family member, appropriate HLA matching is also required. Therefore, additional resources from a public cord blood bank may still be needed.
The Public Cord Blood Bank HLA Matching Service allows you to understand your preliminary HLA matching results in advance, providing additional options for possible future medical needs.

The matching results reflect preliminary matches currently available in the public cord blood bank. Because the bank’s inventory changes over time, a preliminary match does not mean that a specific cord blood unit has been reserved. If a transplant is needed, matching will be reconfirmed based on the resources available at that time.
StemCyte continues to expand its global public cord blood inventory. During the plan’s coverage period, you will receive an updated matching report each year.

If a physician determines that a cord blood transplant is required, StemCyte will, after confirming plan eligibility and fulfillment of the applicable terms and conditions, assist with high-resolution HLA matching, cord blood unit confirmation, and transportation arrangements to the treating medical institution. Certain related expenses may be borne by the user in accordance with the terms of the plan.

Please submit your contact information and partnership requirements through our website inquiry form. A StemCyte representative will contact you to discuss product planning, target customers, and potential partnership models.

Depending on the partner’s needs, the service may be evaluated for inclusion in insurance products, value-added services, or corporate employee benefit programs. The specific partnership structure and applicable requirements will be subject to further discussion and mutual agreement.

Based on its public cord blood bank matching data and service experience, StemCyte can assist partners in evaluating matching criteria and associated risks, and work with them to develop eligibility criteria, service scope, and risk management mechanisms based on their specific needs.